Wholesale Cetrorelix Acetate - Sofosbuvir CAS 1190307-88-0 Purity ≥99.0% (HPLC) API High Quality – Ruifu
Wholesale Cetrorelix Acetate - Sofosbuvir CAS 1190307-88-0 Purity ≥99.0% (HPLC) API High Quality – Ruifu Detail:
Manufacturer with High Purity and Stable Quality
Commercial Supply Sofosbuvir (CAS: 1190307-88-0) and Related Intermediates:
Sofosbuvir CAS: 1190307-88-0
N4-Benzoylcytosine CAS: 26661-13-2
triphenyl(1-[ethoxycarbonyl]ethylidene)phosphorane CAS: 21382-82-1
Pentafluorophenol CAS: 771-61-9
N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester CAS: 1334513-02-8
Name | Sofosbuvir |
CAS Number | 1190307-88-0 |
CAT Number | RF-API06 |
Stock Status | In Stock, Production Scale Up to Hundreds of Kilograms |
Molecular Formula | C22H29FN3O9P |
Molecular Weight | 529.45 |
Brand | Ruifu Chemical |
Item | Specifications |
Appearance | White to Off-White Crystalline Powder |
Purity / Analysis Method | ≥99.0% (HPLC) |
Identification | HPLC RT |
Loss on Drying | ≤0.50% |
Residue on Ignition | ≤0.50% |
Single Unknown Impurity | ≤0.50% |
Total Impurities | ≤1.0% |
Heavy Metals | ≤20ppm |
Melting Point | 95.0~100.0℃ |
Test Standard | Enterprise Standard |
Usage | Sofosbuvir (CAS: 1190307-88-0) in the treatment of Hepatitis C Virus (HCV) |
Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.
Manufacturer with High Purity and Stable Quality
Commercial Supply Sofosbuvir (CAS: 1190307-88-0) and Related Intermediates:
Sofosbuvir CAS: 1190307-88-0
N4-Benzoylcytosine CAS: 26661-13-2
triphenyl(1-[ethoxycarbonyl]ethylidene)phosphorane CAS: 21382-82-1
Pentafluorophenol CAS: 771-61-9
N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester CAS: 1334513-02-8
Sofosbuvir is a drug used for the treatment of hepatitis C. It is recommended to be used in combination with other drugs (such as velpatasvir) for the first-line treatment for HCV genotypes 1, 2, 3, 4, 5, and 6. It takes effect through acting as a nucleotide analog inhibitor, being capable of specially inhibiting the HCV NS5B (non-structural protein 5B) RNA-dependent RNA polymerase. Oral sofosbuvir was generally well tolerated in patients with chronic hepatitis C. The most commonly reported adverse events and laboratory abnormalities in patients receiving sofosbuvir plus ribavirin with or without peginterferon-alpha were consistent with those expected in patients receiving treatment with ribavirin and peginterferon-alpha, and co-administering sofosbuvir did not appear to increase the frequency or severity of these adverse events or laboratory abnormalities.
Product detail pictures:
Related Product Guide:
Our eternal pursuits are the attitude of "regard the market, regard the custom, regard the science" as well as the theory of "quality the basic, believe in the 1st and management the advanced" for Wholesale Cetrorelix Acetate - Sofosbuvir CAS 1190307-88-0 Purity ≥99.0% (HPLC) API High Quality – Ruifu , The product will supply to all over the world, such as: Brunei, Kenya, New Orleans, We always adhere to follow the honesty, mutual benefit, common development, after years of development and the tireless efforts of all staff, now has perfect export system, diversified logistics solutions, thorough meet customer shipping, air transport, international express and logistics services. Elaborate one-stop sourcing platform for our customers!
By Betty from Nepal - 2017.12.09 14:01
Managers are visionary, they have the idea of "mutual benefits, continuous improvement and innovation", we have a pleasant conversation and Cooperation.
By Michaelia from Indonesia - 2018.09.23 18:44